Nanopore Diagnostics is developing a rapid and portable bacterial diagnostic assay.

Our test will allow a physician to make an informed antibiotic decision during their initial examination of a patient, ensuring antibiotics are only administered when truly needed. Our core technology for counting specific nucleic acid biomarkers is quicker, simpler, and more accurate than current methods.

For more information, follow :


  • $600k

Nanopore Diagnostics Articles

St. Louis Startup Roadshow to Boston

19 STL Startups in Boston for STL Roadshow: Here’s What Happened on Day 1

Adarza BioSystems Raises $5 Million in Series B Investment Round

Sparo Labs and Nanopore Diagnostics Raise Over Half a Million Dollars Each

Disrupting Infection with Nanotechnology and Tom Cohen

Arch Grants Announces 2014 Winners

GlobalHack and Olin Cup Winners, Startup Job Fair in St. Louis Announced